NT-I7 (Efineptakin Alfa) in Combination With Pembrolizumab in Participants With Advanced Solid Tumors
Conditions
- Any Advanced Solid Tumors
- Triple Negative Breast Cancer
- Non Small Cell Lung Cancer
- Small Cell Lung Cancer
- Microsatellite Stable Colorectal Cancer
- Pancreatic Cancer
- Ovarian Cancer
Interventions
- DRUG: NT-I7
- DRUG: pembrolizumab (KEYTRUDA®)
Sponsor
NeoImmuneTech
Collaborators